Covered recipient · General Payments record
MARK R MCDONALD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2019–2024
$29,388.42
- Reported across 199 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,707.03 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $842.09 | 20 |
| Alkermes, Inc. | $366.95 | 7 |
| Janssen Pharmaceuticals, Inc | $345.19 | 4 |
| ITI, Inc. | $82.87 | 3 |
| Corium, Inc. | $69.93 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.89 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999951 | CMS |
| ABBVIE INC. | $31.03 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999953 | CMS |
| ABBVIE INC. | $33.61 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999955 | CMS |
| ABBVIE INC. | $26.30 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999957 | CMS |
| ABBVIE INC. | $121.61 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999959 | CMS |
| ABBVIE INC. | $26.66 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999961 | CMS |
| ABBVIE INC. | $28.01 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999963 | CMS |
| ABBVIE INC. | $23.39 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999965 | CMS |
| ABBVIE INC. | $24.54 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999967 | CMS |
| ABBVIE INC. | $123.24 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999969 | CMS |
| ABBVIE INC. | $33.47 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999971 | CMS |
| ABBVIE INC. | $26.25 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999973 | CMS |
| ABBVIE INC. | $33.34 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999975 | CMS |
| ABBVIE INC. | $123.45 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999977 | CMS |
| ABBVIE INC. | $23.38 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999979 | CMS |
| ABBVIE INC. | $14.75 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999981 | CMS |
| ABBVIE INC. | $33.94 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999983 | CMS |
| ABBVIE INC. | $30.28 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999985 | CMS |
| ABBVIE INC. | $28.72 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999987 | CMS |
| ABBVIE INC. | $25.23 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104999989 | CMS |
| Alkermes, Inc. | $26.73 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551059 | CMS |
| Alkermes, Inc. | $28.46 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551061 | CMS |
| Alkermes, Inc. | $98.46 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551063 | CMS |
| Alkermes, Inc. | $28.84 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551065 | CMS |
| Alkermes, Inc. | $30.80 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551067 | CMS |
| Alkermes, Inc. | $31.89 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551069 | CMS |
| Alkermes, Inc. | $121.77 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120551071 | CMS |
| Corium, LLC | $23.68 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100086640 | CMS |
| Corium, LLC | $25.97 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100081491 | CMS |
| Corium, LLC | $20.28 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100178530 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $29.53 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143274858 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.67 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143274861 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.67 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143274865 | CMS |
| Janssen Pharmaceuticals, Inc | $43.99 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077929851 | CMS |
| Janssen Pharmaceuticals, Inc | $133.18 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077929889 | CMS |
| Janssen Pharmaceuticals, Inc | $34.84 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077929687 | CMS |
| Janssen Pharmaceuticals, Inc | $133.18 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077930193 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.